Home › Compare › MEDIF vs BTI

MEDIF vs BTI: Dividend Comparison 2026

MEDIF yields 4345.46% · BTI yields 5.38%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MEDIF wins by $15969693446288.75M in total portfolio value
10 years
MEDIF
MEDIF
● Live price
4345.46%
Share price
$0.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$15969693446288.79M
Annual income
$15,278,069,441,942,714,000.00
Full MEDIF calculator →
BTI
BTI
● Live price
5.38%
Share price
$58.47
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.7K
Annual income
$2,786.64
Full BTI calculator →

Portfolio growth — MEDIF vs BTI

📍 MEDIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDIFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDIF + BTI cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
MEDIF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDIF
Annual income on $10K today (after 15% tax)
$369,364.48/yr
After 10yr DRIP, annual income (after tax)
$12,986,359,025,651,306,000.00/yr
BTI
Annual income on $10K today (after 15% tax)
$457.40/yr
After 10yr DRIP, annual income (after tax)
$2,368.64/yr
At 15% tax rate, MEDIF beats the other by $12,986,359,025,651,304,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDIF + BTI for your $10,000?

MEDIF: 50%BTI: 50%
100% BTI50/50100% MEDIF
Portfolio after 10yr
$7984846723144.41M
Annual income
$7,639,034,720,971,358,000.00/yr
Blended yield
95.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

MEDIF
No analyst data
Altman Z
-2.9
Piotroski
2/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.6% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDIF buys
0
BTI buys
0
No recent congressional trades found for MEDIF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDIFBTI
Forward yield4345.46% ✓5.38%
Annual dividend / share$2.00$3.15 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%11.3% ✓
Portfolio after 10y$15969693446288.79M ✓$37.7K
Annual income after 10y$15,278,069,441,942,714,000.00 ✓$2,786.64
Total dividends collected$15922667488789.34M ✓$14.3K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: MEDIF vs BTI ($10,000, DRIP)

YearMEDIF PortfolioMEDIF Income/yrBTI PortfolioBTI Income/yrGap
1← crossover$445,246$434,546.44$11,299$598.92+$433.9K → MEDIF
2$18,558,681$18,082,267.04$12,794$703.91+$18.55M → MEDIF
3$724,251,944$704,394,155.22$14,518$829.07+$724.24M → MEDIF
4$26,465,566,588$25,690,617,008.13$16,513$978.64+$26465.55M → MEDIF
5$905,687,152,836$877,368,996,586.58$18,827$1,157.84+$905687.13M → MEDIF
6$29,029,592,495,582$28,060,507,242,048.22$21,518$1,373.12+$29029592.47M → MEDIF
7$871,632,797,918,927$840,571,133,948,653.80$24,657$1,632.46+$871632797.89M → MEDIF
8$24,520,223,407,609,444$23,587,576,313,836,190.00$28,329$1,945.74+$24520223407.58M → MEDIF
9$646,377,574,155,211,500$620,140,935,109,069,400.00$32,637$2,325.33+$646377574155.18M → MEDIF
10$15,969,693,446,288,792,000$15,278,069,441,942,714,000.00$37,708$2,786.64+$15969693446288.75M → MEDIF

MEDIF vs BTI: Complete Analysis 2026

MEDIF — Stock

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.

Full MEDIF Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this MEDIF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDIF vs SCHDMEDIF vs JEPIMEDIF vs OMEDIF vs KOMEDIF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.